Di(adamantan-1-yl)(butyl)phosphine hydroiodide, 96%, 10g

Ethylenediaminetetraacetic Acid Lead(II) Disodium Salt>98.0%(T)25g

tert-Butyl 5-chloro-2-oxospiro[indoline-3,4'-piperidine]-1'-carboxylate, 95.0%, 1g

Poly(4-vinylbenzenesulfonic acid), 25g

2-Isopropylmorpholine hydrochloride, 95.0%, 100mg

(3R,4S)-4-Amino-1-methylpyrrolidin-3-ol dihydrochloride, 98%, 1g

4,5,6,7-Tetrahydrobenzo[b]thiophen-2-amine oxalate, 95.0%, 250mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyrimidin-2-amine, 95.0%, 100mg

Thalidomide-O-amido-PEG3-C2-NH2 (TFA), 100mg

2,2,2-Trichloroethyl 2-bromo-2-(3,4-dimethoxyphenyl)acetate, 95%, 100mg

2-OXA-6-AZASPIRO[3.5]NONANE HEMIOXALATE, 95.0%, 250mg

N-Methylmorpholine propylsulfonate inner salt, 99.0%, 1g

Methyl 3-(2-bromoacetyl)benzoate, 95.0%, 250mg